Raphas Co Ltd
KOSDAQ:214260
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/FCFE
Price to Free Cash Flow to Equity (P/FCFE) ratio compares a company`s market value to the free cash flow available to its shareholders. It`s similar to the P/OCF ratio but more precise, since it accounts for capital expenditures deducted from operating cash flow.
Price to Free Cash Flow to Equity (P/FCFE) ratio compares a company`s market value to the free cash flow available to its shareholders. It`s similar to the P/OCF ratio but more precise, since it accounts for capital expenditures deducted from operating cash flow.
Valuation Scenarios
If P/FCFE returns to its 3-Year Average (7.1), the stock would be worth ₩12 316.87 (30% upside from current price).
| Scenario | P/FCFE Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 5.5 | ₩9 500 |
0%
|
| 3-Year Average | 7.1 | ₩12 316.87 |
+30%
|
| 5-Year Average | 7.1 | ₩12 316.87 |
+30%
|
| Industry Average | 16.3 | ₩28 323.72 |
+198%
|
| Country Average | 15.1 | ₩26 189.51 |
+176%
|
Forward P/FCFE
Today’s price vs future free cash flow to equity
Peer Comparison
| Market Cap | P/FCFE | P/E | ||||
|---|---|---|---|---|---|---|
| KR |
R
|
Raphas Co Ltd
KOSDAQ:214260
|
79.9B KRW | 5.5 | 123.3 | |
| FR |
|
L'Oreal SA
PAR:OR
|
195.4B EUR | 19.8 | 31.9 | |
| UK |
|
Unilever PLC
LSE:ULVR
|
93.7B GBP | 16.8 | 11.7 | |
| IN |
|
Hindustan Unilever Ltd
NSE:HINDUNILVR
|
5.3T INR | 55.9 | 36.4 | |
| UK |
|
HALEON PLC
LSE:HLN
|
30.3B GBP | 53.2 | 18.4 | |
| US |
|
Estee Lauder Companies Inc
NYSE:EL
|
27.7B USD | 21.2 | -160.9 | |
| DE |
|
Beiersdorf AG
XETRA:BEI
|
15.5B EUR | 67.1 | 16.5 | |
| JP |
|
Kao Corp
TSE:4452
|
2.7T JPY | 25.2 | 22.1 | |
| IN |
|
Godrej Consumer Products Ltd
NSE:GODREJCP
|
1.1T INR | 73.1 | 59.9 | |
| CA |
|
Relevium Technologies Inc
XTSX:RLV
|
12.2B CAD | 603 | -4 624.4 | |
| IN |
|
Dabur India Ltd
NSE:DABUR
|
783.1B INR | 69.8 | 42.5 |
Market Distribution
| Min | 0.2 |
| 30th Percentile | 8.1 |
| Median | 15.1 |
| 70th Percentile | 28.4 |
| Max | 21 200 |
Other Multiples
Raphas Co Ltd
Glance View
RAPHAS Co., Ltd. engages in the research, development and sale of microarray patches. The company is headquartered in Seoul, Seoul. The company went IPO on 2019-11-11. The firm develops cosmetics based on microstructure technology. In addition, the Company sells cosmetics, pharmaceutical patches, health functional foods under the brand name of Acropass.
